The High Density EEG market is dominated by North America, which holds a 45% market share, driven by advanced healthcare infrastructure, robust R&D investments, and a mature ecosystem for neurodiagnostics. The region benefits from strong policy support, such as FDA approvals for cutting-edge EEG technologies, and high adoption rates in clinical and research settings. Europe follows with 30% growth, fueled by aging demographics, stringent healthcare regulations promoting early diagnostics, and cross-border collaborations in neuroscience. Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 12.5%, supported by rising healthcare accessibility, government-funded neurotech initiatives, and a growing middle-class population prioritizing mental health.